No black box warning on record for Tresiba

As of the latest FDA labeling reviewed, Tresiba (insulin degludec) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tresiba medicine page for the complete safety profile.

Other warnings & precautions

Do not dilute or mix Tresiba with any other insulin.
Hypoglycemia is the most common serious adverse effect — keep rapid-acting glucose available at all times.
Never share pens between patients, even with a new needle.
Verify dose displayed on the FlexTouch pen before injecting (U-100 and U-200 pens dial different units).

No black box warning on record for Tresiba

Other warnings & precautions

Do not dilute or mix Tresiba with any other insulin.
Hypoglycemia is the most common serious adverse effect — keep rapid-acting glucose available at all times.
Never share pens between patients, even with a new needle.
Verify dose displayed on the FlexTouch pen before injecting (U-100 and U-200 pens dial different units).

Tresiba Black Box Warning

No black box warning on record for Tresiba

Other warnings & precautions

Tresiba Black Box Warning

No black box warning on record for Tresiba

Other warnings & precautions